Inventor

William Scott Caldwell

Inventor

Winston-Salem, NC, US

Overview

1993–2012

Patent span

Human necessities

Primary field (CPC A)

Patents· 48 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes35%

C07DHeterocyclic compounds33%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%

C07CAcyclic or carbocyclic compounds3%

Y02ATechnologies for adaptation to climate change1%

PatentTitleYear

8,288,420'Compounds capable of activating cholinergic receptors'2012 7,790,757'Compounds capable of activating cholinergic receptors'2010 7,307,092'Compounds Capable of Activating Cholinergic Receptors'2007 7,060,826'Compounds capable of activating cholinergic receptors'2006 7,045,538'Compounds capable of activating cholinergic receptors'2006 6,979,695'Compounds capable of activating cholinergic receptors'2005 6,958,399'Compounds capable of activating cholinergic receptors'2005 6,624,173'Pharmaceutical compositions for treating and/or preventing CNS disorders'2003 6,603,011'3-pyridinyl compounds'2003 6,555,684'Pyrimidinyl compounds for treatment of central nervous system disorders'2003 6,531,606'Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds'2003 6,525,065'Pharmaceutical compositions and methods for effecting dopamine release'2003 6,492,399'Pharmaceutical compositions and methods for use'2002 6,489,349'Pharmaceutical compositions for inhibition of cytokine production and secretion'2002 6,455,554'Oxopyridinyl pharmaceutical compositions and methods for use'2002 6,417,359'Pharmaceutical compositions and methods for use'2002 6,337,351'Pharmaceutical compositions and methods for use'2002 6,310,102'Pharmaceutical compositions and methods for use'2001 6,274,606'Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds'2001 6,262,124'Pharmaceutical compositions and methods for use'2001 6,232,316'Methods for treatment of CNS disorders'2001 6,107,298'Methods for prevention and treatment of Tourette\'s syndrome and schizophrenia'2000 6,100,269'Pharmaceutical compositions for prevention and treatment of central nervous system disorders'2000 6,057,446'Certain 1-aza-tricyclo [3.3.1-1.sup.3,7 ] decane compounds'2000 5,922,723'Pharmaceutical compositions for prevention and treatment of central nervous system disorders'1999 5,885,998'Methods for prevention and treatment of attention deficit disorder'1999 5,861,423'Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds'1999 5,824,692'Pharmaceutical compositions for prevention and treatment of central nervous system disorders'1998 5,731,314'Pharamceutical compositions for prevention and treatment of tourette\'s syndrome'1998 5,726,316'Pharmaceutical compositions for prevention and treatment of central nervous system disorders'1998 5,616,707'Compounds which are useful for prevention and treatment of central nervous system disorders'1997 5,616,716'(3-(5-ethoxypyridin)yl)-alkenyl 1 amine compounds'1997 5,604,231'Pharmaceutical compositions for prevention and treatment of ulcerative colitis'1997 5,597,919'Pyrimidinyl or Pyridinyl alkenyl amine compounds'1997 5,583,140'Pharmaceutical compositions for the treatment of central nervous system disorders'1996 5,559,124'Depolarizing skeletal muscle relaxants'1996 5,510,355'Depolarizing skeletal muscle relaxants'1996 5,276,043'Method for treatment of neurodegenerative diseases'1994 5,242,916'Method for treatment of neurodegenerative diseases'1993 5,242,935'Method for treatment of neurodegenerative diseases'1993 5,242,934'Method for treatment of neurodegenerative diseases'1993 5,232,932'Method for treatment of neurodegenerative diseases'1993 5,232,933'Method for treatment of neurodegenerative diseases'1993 5,227,385'Method for treatment of neurodegenerative diseases'1993 5,227,391'Method for treatment of neurodegenerative diseases'1993 5,214,060'Method for treatment of neurodegenerative diseases'1993 5,212,188'Method for treatment of neurodegenerative diseases'1993 5,187,169'Method for treatment of neurodegenerative diseases'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–1994Patents assigned to REYNOLDS TOBACCO CO R (10)· patent assignee history

1993–2012Based in Winston-Salem, NC, US· patent location history

2001–2012Patents assigned to TARGACEPT INC (20)· patent assignee history

2012Patents assigned to BHATTI BALWINDER SINGH (1)· patent assignee history

2012Patents assigned to CALDWELL WILLIAM SCOTT (1)· patent assignee history

2012Patents assigned to CROOKS PETER A (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
TARGACEPT INC	20	2001–2012
REYNOLDS TOBACCO CO R	10	1993–1994
BHATTI BALWINDER SINGH	1	2012
CALDWELL WILLIAM SCOTTself	1	2012
CROOKS PETER A	1	2012

Locations

Location	Patents	Span
Winston-Salem, NC, US	48	1993–2012